Derivative exercise or conversion — not an open-market buy.
Traded Aug 31, 2026 · Filed Sep 1, 2026
Encompass Health's Chief Accounting Officer sold $630K of Encompass Health shares. Nobody planned it ahead of time.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
open market sale
Code S — open-market or private sale
~$630,166
Shares × reported transaction price
26 days after results of Aug 5, 2026
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
None found in footnotes
Only flagged when a footnote says so; never inferred
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | +0.3% | −0.4% | +0.6% |
| 30 days | −1.1% | +0.6% | −1.7% |
Past results only. Not a forecast.
Derivative exercise or conversion — not an open-market buy.
Encompass Health's Gen Counsel & Secretary sold $588K of Encompass Health shares. Nobody planned it ahead of time.
Derivative exercise or conversion — not an open-market buy.